Synergistic Therapeutic Microvesicle Systems

Publication ID: 24-11857582_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Therapeutic Microvesicle Systems,” Published Technical Disclosure No. 24-11857582_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857582_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,582.

Summary of the Inventive Concept

Integrating patented therapeutic microvesicles with AI, IoT, blockchain, and nanomaterials to create a more powerful, personalized, and efficient system for treating gastrointestinal disorders

Background and Problem Solved

The original patent disclosed therapeutic microvesicles of probiotic bacteria, but limitations in production, quality control, and patient treatment outcomes necessitate the development of more advanced systems. This inventive concept addresses these limitations by combining the patented microvesicles with cutting-edge technologies

Detailed Description of the Inventive Concept

The synergistic system comprises a therapeutic microvesicle composition, an AI-powered quality control system, a blockchain-based tracking system, a nanomaterial-based delivery system, and an IoT-enabled device for real-time monitoring. The system enables personalized treatment, enhanced microvesicle production, and secure tracking of patient outcomes. The AI-powered quality control system ensures microvesicle purity and consistency, while the blockchain-based tracking system guarantees the authenticity of the microvesicles. The nanomaterial-based delivery system targets the release of microvesicles in the gut, and the IoT-enabled device monitors treatment efficacy in real-time

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, blockchain, and nanomaterials with the patented therapeutic microvesicles, providing a non-obvious and innovative solution to the limitations of the original patent

Alternative Embodiments and Variations

Alternative embodiments may include using different AI algorithms, blockchain platforms, or nanomaterials. Variations could involve integrating the synergistic system with other healthcare technologies, such as telemedicine or electronic health records

Potential Commercial Applications and Market

The synergistic therapeutic microvesicle system has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the treatment of gastrointestinal disorders. The system's ability to provide personalized, efficient, and secure treatment outcomes could revolutionize the industry and create new market opportunities

Original Patent Information

Patent NumberUS 11,857,582
TitleTherapeutic microvesicles of probiotic bacteria
Assignee(s)BioGaia AB